Marinus Pharmaceuticals Q1 Financial Results: Key Insights

Tuesday, 5 March 2024, 21:05

The Q1 financial results of Marinus Pharmaceuticals have shown a shortfall in GAAP EPS, with a figure of -$0.74 missing estimates by $0.12. Similarly, the revenue of $7.19M fell short by $0.95M. This report indicates challenges in the company's financial performance during the first quarter.

LivaRava Finance Meta Image — Marinus Pharmaceuticals Q1 Financial Results: Key Insights

Marinus Pharmaceuticals Q1 Financial Results Update

The recent quarterly financial report of Marinus Pharmaceuticals revealed a notable discrepancy in the GAAP EPS and revenue figures. The GAAP EPS of -$0.74 came in below expectations, falling short by $0.12. Additionally, the revenue for the quarter amounted to $7.19M, missing forecasts by $0.95M. These results suggest potential challenges ahead for Marinus Pharmaceuticals.

This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.

Marinus Pharmaceuticals Q1 Financial Results Update

Related posts